SCHEMBL19663799

SCHEMBL19663799

CC(=O)N[C@H]1Cc2c(C)c(C)cc(C(=O)OCOC(=O)C(C)(C)C)c2OB1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19663798 0.87 TSHR (0.33) —
SCHEMBL17347822 0.86 — —
SCHEMBL23129713 0.86 — —
SCHEMBL23129894 0.86 — —
SCHEMBL17347802 0.86 — —
SCHEMBL17347816 0.82 PRKCB (0.33) —
SCHEMBL23129714 0.82 PRKCB (0.33) —
SCHEMBL23130039 0.81 PARP1 (0.32) —
SCHEMBL17347844 0.81 PRKCB (0.31) —
SCHEMBL17347799 0.81 PARP1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342092-A1 BETA-LACTAMASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-11-30 — — US disclosed
Send feedback